BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Polivka J, Windrichova J, Pesta M, Houfkova K, Rezackova H, Macanova T, Vycital O, Kucera R, Slouka D, Topolcan O. The Level of Preoperative Plasma KRAS Mutations and CEA Predict Survival of Patients Undergoing Surgery for Colorectal Cancer Liver Metastases. Cancers (Basel) 2020;12:E2434. [PMID: 32867151 DOI: 10.3390/cancers12092434] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Passardi A, Marisi G, Ulivi P. Metastatic Colorectal Cancer. Cancers (Basel) 2021;13:6346. [PMID: 34944966 DOI: 10.3390/cancers13246346] [Reference Citation Analysis]
2 Zhao J, Jiang O, Chen X, Liu Q, Li X, Wu M, Zhang Y, Zeng F. Development and validation of a prediction model for metastasis in colorectal cancer based on LncRNA CRNDE and radiomics. MedComm – Future Medicine 2022;1. [DOI: 10.1002/mef2.6] [Reference Citation Analysis]
3 Diener MK, Fichtner-Feigl S. Biomarkers in colorectal liver metastases: Rising complexity and unknown clinical significance? Ann Gastroenterol Surg 2021;5:477-83. [PMID: 34337296 DOI: 10.1002/ags3.12454] [Reference Citation Analysis]
4 Berg KCG, Brunsell TH, Sveen A, Alagaratnam S, Bjørnslett M, Hektoen M, Brudvik KW, Røsok BI, Bjørnbeth BA, Nesbakken A, Lothe RA. Genomic and prognostic heterogeneity among RAS/BRAFV600E /TP53 co-mutated resectable colorectal liver metastases. Mol Oncol 2021;15:830-45. [PMID: 33325154 DOI: 10.1002/1878-0261.12885] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
5 Gong J, Hendifar A, Gangi A, Zaghiyan K, Atkins K, Nasseri Y, Murrell Z, Figueiredo JC, Salvy S, Haile R, Hitchins M. Clinical Applications of Minimal Residual Disease Assessments by Tumor-Informed and Tumor-Uninformed Circulating Tumor DNA in Colorectal Cancer. Cancers (Basel) 2021;13:4547. [PMID: 34572774 DOI: 10.3390/cancers13184547] [Reference Citation Analysis]